April 16, 2012Date Released: 16 April 2012
MESSAGE FROM THE DIRECTOR
Stan Gerson, MD
We are the final throes of the NCI renewal application due at the end of May. Preparation for this application has involved more than 65 faculty and another 80 staff who have active roles in Cancer Center programs and shared resources. I am happy to say the contributions of ALL of our 326 members are noted. Having reviewed every page and word so far, I am confident this submission will reflect the powerful impact our Cancer Center makes to shift the paradigms of cancer biology, change cancer treatment, and reduce the risk of cancer by population studies and early detection.
This year, our usual summer scientific retreat will be restricted to a focus on the October NCI site visit. We ask all of the Cancer Center leadership, program leaders, core directos, and members of the clinical research office and units to participate. This retreat will be held at the time normally reserved for the scientific retreat (date TBD). For this reason, this summer we will not attempt to also hold a normal retreat as we prepare for the site visit. During this time, however, the Cancer Center and programs will continue to hold conferences, small retreats, project initiatives, and other activities that the Cancer Center will support.
Many of you will be called upon to give input for program and core facility preparations for the site visit. Speaking for the entire leadership team of the Cancer Center, I appreciate the time and effort that has gone into the core grant renewal. We have a great consortium cancer center, and your discoveries and efforts are reflected in our grant submission.
CASE CCC IN THE NEWS
Breakthrough Discovery Unveils "Master Switches" in Colon Cancer
Study Links Dental X-rays to Brain Tumors
Battling the Odds in RCC: An Interview With Brian Rini, MD
MARK YOUR CALENDARSTumor Microenvironment Meeting
At least four of the programs of the Case CCC Programs–Cancer Signaling, GU Malignancies, Developmental Therapeutics, and Cancer Imaging - have themes or aims related to the tumor microenvironment: angiogenesis and endothelial cells, immune effectors and immunotherapy, and the matrix, adhesion, and stroma. Discussion sessions were started in 2011 by Dr. Danny Manor for Signaling and have been extended in 2012 to include imaging, angiogenesis, and invasion. We anticipate continuing these sessions approximately monthly through 2012 and 2013. We hope that these talks will lead eventually to basic/translational projects and/or collaborative grants, and maybe down the road enough commonality to plan towards P01s in the topic areas of focus.
The next session will be on immune effector mechanisms and interventions and will be held April 18 from 5-7:30pm at the Taussig Cancer Institute R3-027 with light dinner fare, including wine and cheese. Talks will be 20-25 minutes followed by discussion. Presentations will be as follows:
Cancer Center Seminar Series: Molecular and Functional Imaging of Cancer: Windows into an Impenetrable
Disease Friday, April 20
Please join us April 20 for the next Cancer Center Seminar Series where Dr. Zaver M. Bhujwalla, Professor of Radiology & Radiological Science and Oncology and Director of the In Vivo Cellular Molecular Imaging Center at Johns Hopkins University, will present Molecular and Functional Imaging of Cancer: Windows into an Impenetrable Disease.
Dr. Bhujwalla's main research interests involve understanding the role of the physiological environment and vascularization in tumor progression, invasion and metastasis. The Bhujwalla laboratory employs both in vivo and isolated perfused cell systems. They mainly use multinuclear Magnetic Resonance (MR) Imaging (I) and Spectroscopy (S) for studying cancer cell physiology and metabolism. Research studies are performed on established human breast cancer and prostate cancer lines. Another area of research is detecting the response of tumors to radiation and chemotherapy with MR methods. They also use multinuclear MR methods for pharmokinetic and pharmodynamic studies.Case GI SPORE Retreat
The Case Gastrointestinal Cancers SPORE Retreat will be held Friday, May 4 in Dively Hall on Case campus. Topics will include colon cancer, Barrett's Esophagus, cancer metastasis and prevention and cancer in minorities. Faculty, fellows and students in the Cancer Center community are encouraged to attend and learn more about exciting findings from researchers in the specialized program of research excellence.
The retreat will also feature a lunchtime poster session that starts at 12 pm. Postdoc, graduate and clinical fellows are encouraged to submit poster abstracts. Send poster abstracts to John Wang, PhD by today, April 16. A cash prize will be awarded for best poster.
Advance registration is required. Contact John Pounardjian with any questions.
FUNDING OPPORTUNITYBETRNet Pilot Funding
Faculty members with an appointment at the Assistant Professor level or higher at participating institutions are invited to submit applications for individual and/or crossBarrett's Esophagus Translational Research Network (BETRNet) pilot projects. Participating institutions include CWRU, University of Pennsylvania, Fred Hutchinson Cancer Research Center, Johns Hopkins, University North Carolina, Washington University, and Mayo Clinic. BETRNet projects must be directed toward translational research related to Barrett's Esophagus or Esophageal Adeno Carcinoma. At least one specific aim should involve either direct patient contact or the study of patient derived tissue samples.
Deadline: May 18
ANNOUNCEMENTSeBioscience Support for TRCCC
All members of the Case CCC are now entitled to substantial discounts from eBioscience for many of their products. This arrangement has been made recently as part of eBiosciences commitment to support the Translational Research Cancer Centers Consortium (TRCCC) and their annual meeting in Seven Springs, PA.
These discounts are outlined in the flyer and include:
The discounts are valid for participating members of the Translational Research Cancer Centers Consortium (TRCCC) until December 31, 2012.
Please setup sales quotations with local account manager, Keith Olszens at firstname.lastname@example.org.
**All events are open to anyone interested in attending
Frontiers in Molecular Medicine Symposium Series
Physiology and Biophysics Seminar
Skeletal Research Center Seminar
Cancer Biology Candidate Seminar
Immunology Seminar Series
Hematology and Oncology Division Research Conference
OnCore Clinical Trials Management System Training Class
Tumor Microenvironment Meeting
Comparative Effectiveness Seminar Series
Frontiers in Chemistry
Taussig Cancer Institute Grand Rounds
Cancer Center Seminar Series
Cancer Center Research in Progress Seminar
Dean's Distinguished Lecture
Case CCC Calendar
UPCOMING CANCER CENTER SYMPOSIUMS & EVENTS
Case GI Cancers SPORE Retreat
Breast Cancer 2012: Risk Assessment through Survivorship
Case CCC Scientific Series: Imaging Research
Ca-PRI Annual Meeting: Learning from Our Differences
ADDITIONAL UPCOMING SEMINARS & EVENTS
Department of Biomedical Engineering Special Seminar
PREVIOUSLY ANNOUNCED OPPORTUNITIES
DOD Ovarian Cancer Research Program Ovarian Cancer Academy Award
DOD Prostate Cancer Research Program Synergistic Idea Development Award
NIH BULLETIN – Notices and Funding Opportunities
NLM Administrative Supplements for Informationist Services in NIH-funded Research Projects (Admin Supp)(PA-12-158)
Basic Research on HIV Persistence (R01)(PA-12-161)
Basic Research on HIV Persistence (R21)(PA-12-162)
Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R21)(PAR-11-216)
HELP US HELP YOU!
If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades!
Send items to email@example.com.